The Health 202: There will be a big fight over Trump’s new proposal to lower drug prices image

Washington Post, October 26, 2018
Paige Winfield Cunningham, quoting Rachel Sachs (Academic Fellow Alumna)


Read the Full Article

From the article:

But the plan does signify the administration is serious about taking action on drug prices. The Obama administration made a similar effort, which it ultimately abandoned under pressure from the drug industry.

Rachel Sachs, an associate professor of law at Washington University School of Law in St. Louis, questioned why the Trump administration would echo a move by its predecessors. 

“It’s very interesting that the administration has decided to bring back a proposal that was roundly criticized and ultimately abandoned by the Obama administration,” Sachs said. “It will be interesting to see whether they can withstand the kind of criticism that the Obama administration took from many sides of this issue and if not, it’s a sign that this administration is business as usual. If so, we won’t know for several years.”

Read more here!

health law policy pharmaceuticals rachel sachs regulation